Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model

Prostate

Volumn 28, Issue 2, 1996, Pages 98-106

  Bonkhoff, Helmut ^a   Remberger, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

benign prostate hyperplasia; prostate cancer; stem cell model

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; STEM CELL;

ADENOCARCINOMA; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; EPITHELIUM; HUMANS; MALE; NEOPLASM INVASIVENESS; PHENOTYPE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STEM CELLS;

EID: 0030021453     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J     Document Type: Article

References (52)

1. Carter HB, Coffey DS: The prostate: an increasing medical problem. Prostate 16:39-48, 1990.
2. Chiorado A: Prostatic cancer working group, National Cancer Institute round-table on prostate cancer: future research direction. J Cancer Res 51:2498-2505, 1991.
3. Aumüller G: Morphologic and endocrine aspects of prostatic function. Prostate 4:195-214, 1983.
4. Fickinger CJ: Ultrastrctural observations on the postnatal development of the rat prostate. Z Zellforsch 113: 157-173, 1971.
5. Dermer GB: Basal cell proliferation in benign prostatic hyperplasia. Cancer 41:1857-1862, 1978.
6. Bazer GT: Basal cell proliferation and differentiation in regeneration of the rat ventral prostate. Invest Urol 17: 470-473, 1980.
7. Kastendieck H. Altenähr E: Cyto- and histomorphogenesis of the prostate carcinoma: a comparative light and electron microscopic study. Virchows Arch [A] 370: 207-224, 1976.
8. Trump BF, Heatfield BM, Phelps PC: In Murphy GP, Sandberg Aa, Karr JP (eds): "The prostatic cell structure and function." New York: Alan R. Liss, 1981, pp 25-53.
9. Heatfield BM, Sanefugi M, Trump BF: Studies on carcinogenesis of human prostate. III. Long term explant culture of normal prostate and benign prostatic hyperplasia: transmission and scanning electron microscopy. J Natl Cancer Inst 69:757-766, 1982.
10. Merchant DJ, Carke SM, Ives K, Harris S: Primary explant culture: an in vitro model of the human prostate. Prostate 4:523-542, 1983.
11. Di Sant' Agnese PA: Neuroendocrine differentiation in human prostate carcinoma. Hum Pathol 23:287-296, 1992.
12. Di Sant' Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic prognostic, and therapeutic implications. Cancer 70:254-268, 1992.
13. Wernert N, Seitz G, Achtstätter T: Immunohistochemical investigations of different cytokeratins and vimentin in the prostate from fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 182:617-626, 1987.
14. Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A: Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 47:281-286, 1987.
15. Sherwood ER, Berg LA, Mitchell NJ, McNeal JE, Kozlowski JM, Lee C: Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol 143:167-171, 1990.
16. Isaacs JT, Coffey DS: Etiology and disease process of benign prostatic hyperplasia. Prostate 2:33-50, 1989.
17. Masai M, Sumiya H, Akimoto S, Yatani R, Chang C, Liao S, Shimazaki J: Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 17:293-300, 1990.
18. Ruizeveld de Winter JA, Trapman J, Brinkmann AO, Boersma WJA, Mulder E, Schroeder FH, Claassen E, van der Kwast TH. Androgen receptor heterogenity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol 161:329-332, 1990.
19. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CCJ, Mulder E, Boersma W, Trapman J: Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer 48:189-193, 1991.
20. Dhom G, Seitz G, Wernert N: Histology and immunohistochemistry studies in prostate cancer. Am J Clin Oncol (Suppl. 2) 11:537-547, 1988.
21. Nagle RB, Brawer MK, Kittelson J, Clark V: Phenotypic relationship of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 138:119-128, 1991.
22. Okada H, Tsubura A, Okamura A, Senzaki H, Naka Y, Komatz Y, Morii S: Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch [A] 421:157-161, 1992.
23. English HF, Santen RJ, Isaacs JT: Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229-242, 1987.
24. Evans GS, Chandler J: Cell proliferation studies in rat prostate. I. The proliferative role of basal and secretory epithelial cells during normal growth. Prostate 10:163-178, 1987.
25. Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G: Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch [A]412:387-391, 1988.
26. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24:114-118, 1994.
27. Hockenbery D, Nunez G, Milliman C, Schreiber R, Korsmeyer SJ: BCL-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990.
28. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965, 1991.
29. Bonkhoff H: Formale Pathogenese der Prostatahyperplasie und des Prostatakarzinoms. Ein Differenzierungs und Proliferationsmodell. PhD Thesis, Homburg (Saar), Germany: University of the Saarland, 1994.
30. Colombel M, Symmans F, GE S, O'Toole K, Chopin D, Benson M, Olsson C, Korsmeyer S, Buttgan R: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refactory human prostate cancer. Am J Pathol 143:390-400, 1993.
31. Bonkhoff H, Wernert N, Dhom G, Remberger K: Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic and neoplastic human prostate. Prostate 18:91-98, 1991.
32. Bonkhoff H, Stein U, Remberger K: Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol 26:167-170, 1995.
33. Bonkhoff H, Remberger K: Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch [A] 422:35-38, 1993.
34. Bonkhoff H, Stein U, Remberger K: Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Arch [A] 423:291-294, 1993.
35. Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate. Simultaneous demonstration of cell specific epithelial markers. Hum Pathol 25:42-46, 1994.
36. Cheng H, Leblond CP: Origin, differentiation and renewal of the four main epithelial types in the mouse small intestine. V. Unitarian theory of the four epithelial cell types. Am J Anat 141:537-562, 1974.
37. Kirkland S: Clonal origin of columnar, mucous and endocrine cell lineages in human colorectal epithelium. Cancer 61:1359-1363, 1988.
38. Tumm S, Hochstrate H, St Grunwald H, Flüchter T, Krieg M: Effect of aging on kinetic parameters of 5 alpha reductase in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 67:979-985, 1988.
39. Krieg M, Nass R, Tumm S: Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate (BPH). J Clin Endocrinol Metab 77:1993 (in press).
40. Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM: Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 4:22-28, 1990.
41. Shan LX, Rodriguez MC, Janne OA: Regulation of androgen receptor protein and mRNA concentration by androgens in the rat ventral prostate and seminal vesicles and in human hepatoma cells. Mol Endocrinol 4:1636-1646, 1990.
42. Brawer MK: Prostatic intraepithelial neoplasia. A premalignant lesion. Hum Pathol 23:242-248, 1992.
43. Jones E, Young R: The differential diagnosis of prostate carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland. Am J Clin Pathol 101:48-64, 1994.
44. Terpstra OT, Blankenstein M, Dees J, Eilers GAM: Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 92:704-708, 1987.
45. Timpl R, Dziadek T: Structure, development and molecular pathology of basement membranes. Int Rev Exp Pathol 29:1-109, 1986.
46. Hynes RO: Integrins: a family of cell surface receptors. Cell 48:549-554, 1987.
47. Liotta LA, Rao CN: Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem 55:1037-1052, 1986.
48. Albelda SM: Biology of disease. Role of integrins and other cell adhesion molecules in tumor progression and metastases. Lab Invest 68:4-17, 1993.
49. Bonkhoff H, Wernert N, Dhom G, Remberger K: Basement membrane in fetal, adult normal, hyperplastic and neoplastic human prostate. Virchows Arch [A] 418: 375-381, 1991.
50. Bonkhoff H, Wernert N, Dhom G, Remberger K: Distribution of basement membranes in primary and metastatic carcinomas of the prostate. Hum Pathol 23:934-939, 1992.
51. Bonkhoff H, Stein U, Remberger K: Differential expression of alpha-6 and alpha-2 very late antigen integrins in the normal, hyperplastic and neoplastic human prostate. Simultaneous demonstration of cell surface receptors and their extracellular ligands. Hum Pathol 24:243-248, 1993.
52. Ruizeveld de Winter JA, Janson PJA, Sleddens HMFB, Verleun-Mooijman, MCT, Trapman J, Brinkmann AO, Santerese AB, Schröder FH, van der Kwast TH: Androgen receptor status in localized and locally progressive, hormone refractory prostate cancer. Am J Pathol 144: 735-746, 1994.